Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kendle International Inc. (KNDL) -- Ignore unavailable to you. Want to Upgrade?

To: Alan M. Solinger who wrote (8)	2/19/1998 11:48:00 AM
From: Jeff Mulder	Read Replies (1) \| Respond to of 53

Alan, I appreciate your insights. It's nice to get an objective perspective on a company here, rather than the cheerleading found on many boards. BTW, who do you consider to be the CRO industry leaders? If you didn't already see it, KNDL released their Q4 and FY97 results this morning, which explains the pop in stock price. I don't own the stock. But I might bite if the price moves into the $18-$20 range. (Part of the CANSLIM discipline is buying stocks only within 5% of their breakout points.) - Jeff